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The complications of autosomal dominant polycystic kidney disease (ADPKD) include cyst rupture and haemorrhage leading to
loin pain and frank haematuria. Risk factors include large kidney volume, hypertension, and renal impairment. We present a case
of a young male who, following trauma to the kidney, had a life threatening bleed from his polycystic kidney. The case was initially
treated with fluid resuscitation and blood transfusion but necessitated radiological embolization of bleeding source to control the
blood loss. We review the risk factors and management of cyst haemorrhage in patients with ADPKD. Contact sports should be
avoided as cyst rupture can lead to severe life threatening haemorrhage.
1. Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is
characterised by the progressive development and enlarge-
ment of kidney cysts throughout the renal tissue, which leads
to increases in renal volume and ultimately renal failure.
Cysts may also affect other organs, typically the liver. A mea-
surement of height adjusted renal volume allows prediction
of progression to end stage renal disease [1]. Haematuria is
a common renal manifestation of ADPKD [2]. Haematuria
may often be visible and can be the presenting feature of this
disease [3]. A urinary tract infection or strenuous activity
may precipitate an episode of frank haematuria, and episodes
may be recurrent. Haematuria is most often secondary to
the rupture of a kidney cyst, which may present with pain
alone or pain followed by haematuria. Conservative therapy
usually allows resolution of the haematuria over several days
however there may bleeding from ruptured cysts that lasts
for weeks or is severe enough to warrant intervention with
arterial embolization. We present a case of a patient with
ADPKD complicated by a life threatening bleed.
2. Case Presentation
A 25-year-old male with a known diagnosis of autosomal
dominant polycystic kidney disease (ADPKD), with pre-
served renal function, presentedwith sudden onset severe left
flank, following a rugby game. The loin pain was associated
with frank haematuria. On examination, he had severe
tenderness to his left hypochondrium and renal angle. Hewas
tachycardic and blood pressure was elevated at an average of
160/90 from a baseline of 130/80. A CT abdomen (Figures
1(a), 1(b), and 1(c)) revealed a large left sided haemorrhage
surrounding the polycystic kidney which extended into
the retroperitoneum. The renal lengths and volumes were
15.7 cm and 571mL, respectively, on the right and 16.0 cm
and 732mL, respectively, on the left. He was managed
supportively with intravenous fluids (0.9% sodium chloride
solution, 125mLs/h), analgesia (including paracetamol and
codeine), and haemodynamicmonitoring. Twelve hours after
presentation his haemoglobin dropped from 132 g/L to 60 g/L
with an associated fall in haematocrit, but with maintenance
of blood pressure. This was treated with a blood transfusion
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Figure 1: Computerised tomography (CT) of abdomen and left renal arteriogram and embolization of a patient with autosomal dominant
polycystic kidney disease demonstrating large left renal retroperitoneal haemorrhage. Sagittal views (a and b) and (c) axial view of contrast
enhanced CT abdomen showing bilateral polycystic kidneys with evidence of large volume haemorrhage which surrounds the left kidney
and extends into the retroperitoneal space. Super-selective angiogram of the left renal artery lower polar segmental branch showing an
extravasation into the lower polar renal cyst (d) and final, postembolization angiogram confirming satisfactory exclusion of the source of
bleed (e and f).
(3 units packed red cells) and radiological embolization of the
bleeding source (Figures 1(d), 1(e), and 1(f)). Renal function
remained stable and the patient improved without the need
for further intervention. He was advised to avoid contact
sports in future and his haematuria and pain resolved within
two weeks.
3. Discussion
Up to 70% of patients with ADPKD develop cyst haem-
orrhage and haematuria due to rupture into the collecting
system which is usually self-limiting [4, 5]. The risk of
haemorrhage is increased with increasing kidney volume,
especially if kidneys are greater than 15 cm in length, as was
the case here, or if there is hypertension or renal impairment
[3, 6]. Patients with PKD1 mutations generally have a more
severe disease course than patient with PKD2mutations, with
a larger number of cysts and a faster progression of disease.
Episodes of frank haematuria below the age of 30 years have
been associated with risk of rapid disease progression [7] and
a urological event before the age of 35; for example, frank
haematuria contributes to an increase in PROPKD score, a
recently developed algorithm to predict renal outcomes in
ADPKD[8]. Patients affectedwithADPKDshould be advised
to avoid contact sports (such as boxing, rugby, and American
football) because of the associated cyst rupture risk. Useful
information regarding lifestyle can be found on the PKD
charity website (http://www.pkdcharity.org.uk/).
Haematuria is mostly managed conservatively with intra-
venous fluids and analgesia. In cases of prolonged bleeding,
clot formation can occur causing renal tract obstruction. In
this instance, a three-way catheter and bladder irrigation are
required and if bleeding persists for over 2 weeks, ureteric
stenting may be necessary. In severe bleeding and extensive
haematomas, blood transfusion, percutaneous transcatheter
renal artery embolization, or even surgical approaches such
as nephrectomy may be necessary [9]. Other important
differential diagnoses of renal angle tenderness in a patient
with ADPKD include cyst infection, cyst enlargement,
pyelonephritis, nephrolithiasis, and tumours, including renal
cell carcinoma [9].
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